Nanobiotix S.A. (NBTX)

Nanobiotix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	2,164	1,119	136	269	128	282
Market Cap Growth	1213.16%	724.71%	-49.54%	110.26%	-54.62%	-50.38%
Enterprise Value	2,213	1,164	131.83	236.14	135.69	229.54
Last Close Price	46.20	23.13	2.87	7.28	3.67	8.10
PS Ratio	56.54	29.28	-18.14	6.72	24.97	93.68
PB Ratio	-	-11.29	-1.99	-132.04	-4.41	9.26
P/TBV Ratio	-26.15	-13.09	-2.07	-145.97	-4.73	10.50
EV/Sales Ratio	57.83	30.45	-17.62	5.90	26.49	76.26
Debt / Equity Ratio	-1.08	-1.08	-0.70	-24.71	-1.80	1.41
Net Debt / Equity Ratio	-0.50	-0.50	-0.02	13.41	-0.44	-1.41
Net Debt / EBITDA Ratio	-4.99	-4.57	-0.02	0.98	-0.26	0.74
Net Debt / FCF Ratio	-1.25	-1.25	-0.06	1.93	-0.32	1.26
Asset Turnover	0.48	0.48	-0.09	0.47	0.06	0.02
Quick Ratio	0.95	0.95	0.89	1.53	1.09	2.28
Current Ratio	1.09	1.09	1.04	1.75	1.38	2.53
Return on Equity (ROE)	31.91%	31.91%	201.73%	274.85%	44738.80%	-96.66%
Return on Assets (ROA)	-16.01%	-16.01%	-84.92%	-34.96%	-57.83%	-44.60%
Return on Invested Capital (ROIC)	-612.30%	-612.30%	6925.53%	-587.94%	-464.18%	-549.50%
Return on Capital Employed (ROCE)	-115.48%	-115.48%	-260.51%	-81.32%	-107.66%	-58.45%
Buyback Yield / Dilution	-1.17%	-1.17%	-27.99%	-5.96%	-0.34%	-42.43%
Total Shareholder Return	-1.17%	-1.17%	-27.99%	-5.96%	-0.34%	-42.43%

Updated Feb 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q